Literature DB >> 9425253

Mitochondrial DNA mutations in Alzheimer's disease.

T P Hutchin1, P R Heath, R C Pearson, A J Sinclair.   

Abstract

Several reports have indicated that point mutations of the mitochondrial DNA (mtDNA) contribute to the pathogenesis of Alzheimer's disease (AD). However, other groups have failed to find similar associations between these mutations and AD. A recent report described a set of mutations in the mtDNA encoded cytochrome oxidase genes which may account for 20% of all AD cases. We screened brain tissue from 65 AD patients for each of these previously reported mtDNA mutations but were unable to find an increased incidence of any of them in our AD sample. However, one patient with a mutation in the APP gene did harbour a novel mtDNA mutation (G to C at position 5705 in the tRNAAsn gene) that might have contributed to the very early onset of dementia in this individual. The role of mtDNA mutations in the pathogenesis of AD remains unclear, but they do not appear to be primary causes but may contribute to the onset of the disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9425253     DOI: 10.1006/bbrc.1997.7793

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Mitochondrial DNA analysis: polymorphisms and pathogenicity.

Authors:  P F Chinnery; N Howell; R M Andrews; D M Turnbull
Journal:  J Med Genet       Date:  1999-07       Impact factor: 6.318

Review 2.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

3.  Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia.

Authors:  Pinar E Coskun; Joanne Wyrembak; Olga Derbereva; Goar Melkonian; Eric Doran; Ira T Lott; Elizabeth Head; Carl W Cotman; Douglas C Wallace
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Mitochondrial DNA sequence variation associated with dementia and cognitive function in the elderly.

Authors:  Gregory J Tranah; Michael A Nalls; Shana M Katzman; Jennifer S Yokoyama; Ernest T Lam; Yiqiang Zhao; Sean Mooney; Fridtjof Thomas; Anne B Newman; Yongmei Liu; Steven R Cummings; Tamara B Harris; Kristine Yaffe
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 5.  Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas.

Authors:  Estela Area-Gomez; Cristina Guardia-Laguarta; Eric A Schon; Serge Przedborski
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

Review 6.  Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?

Authors:  Haibo Wang; Prakash Dharmalingam; Velmarini Vasquez; Joy Mitra; Istvan Boldogh; K S Rao; Thomas A Kent; Sankar Mitra; Muralidhar L Hegde
Journal:  Mech Ageing Dev       Date:  2016-09-20       Impact factor: 5.432

7.  Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage.

Authors:  Maria Manczak; Byung S Park; Youngsin Jung; P Hemachandra Reddy
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 8.  Mitochondrial medicine for neurodegenerative diseases.

Authors:  Heng Du; Shirley ShiDu Yan
Journal:  Int J Biochem Cell Biol       Date:  2010-01-11       Impact factor: 5.085

9.  Mitochondrial DNA sequence associations with dementia and amyloid-β in elderly African Americans.

Authors:  Gregory J Tranah; Jennifer S Yokoyama; Shana M Katzman; Michael A Nalls; Anne B Newman; Tamara B Harris; Matteo Cesari; Todd M Manini; Nicholas J Schork; Steven R Cummings; Yongmei Liu; Kristine Yaffe
Journal:  Neurobiol Aging       Date:  2013-10-18       Impact factor: 4.673

Review 10.  A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy.

Authors:  Kundlik Gadhave; Deepak Kumar; Vladimir N Uversky; Rajanish Giri
Journal:  Med Res Rev       Date:  2020-08-11       Impact factor: 12.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.